REGN
Regeneron Pharmaceuticals, Inc. · BMV:REGN
13,352.00 MXN0.00 0.00%
Regeneron Pharmaceuticals, Inc. (BMV:REGN) last traded at 13,352.00 MXN, unchanged on the day. Over the past year the stock is up 9.44%. Its 52-week range is 10,270.00 to 14,288.78. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open13,352.00
Day range13,352.00 – 13,352.00
52-week range10,270.00 – 14,288.78
Volume2
Average volume (10 days)30
Market cap (USD)95.51 B
P/E16.30
EPS (TTM) (USD)45.30
Dividend yield0.40%
Beta (1 year)0.2378
Revenue (TTM) (USD)16.90 B
Employees15.41 K
Performance
0.00%1 week
−2.52%1 month
+5.20%3 months
+12.97%6 months
−1.53%Year to date
+9.44%1 year
Technical reading
Neutral
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Regeneron Pharma Price Target Raised to $855.00/Share From $779.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains Regeneron Pharmaceuticals at Equal-Weight, raises price target to $855 from $779TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $913.00/Share From $810.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $982.00/Share From $780.00 by Truist SecuritiesDow Jones Newswires · 02 Nov 2026
- Truist Securities maintains Regeneron Pharmaceuticals at Buy, raises price target to $982 from $780TradingView · 02 Nov 2026
- RBC Capital maintains Regeneron Pharmaceuticals at Sector Perform, raises price target to $913 from $810TradingView · 02 Nov 2026
- Regeneron Pharma Is Maintained at Buy by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim maintains Regeneron Pharmaceuticals at Buy, raises price target to $1100 from $1030TradingView · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.